5-HT2C receptor sensitivity after chronic paroxetine administration in the presence or absence of the 5-HT1A receptor antagonist WAY100635

被引：0
|
作者：
Starr, KR [1 ]
Duxon, MS [1 ]
Upton, N [1 ]
机构：
[1] SmithKline Beecham Pharmaceut, Neurosci Res, Harlow CM19 5AD, Essex, England
来源：
EUROPEAN JOURNAL OF NEUROSCIENCE | 2000年 / 12卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：473 / 473
页数：1
相关论文
共 50 条
  • [31] The effects of antipsychotics with 5-HT2C receptor affinity in behavioral assays selective for 5-HT2C receptor antagonist properties of compounds
    Prinssen, EPM
    Koek, W
    Kleven, MS
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 388 (01) : 57 - 67
  • [32] CHRONIC TREATMENT WITH PAROXETINE AND FLUOXETINE, BUT NOT DESIPRAMINE, DESENSITIZES 5-HT2C RECEPTOR FUNCTION
    KENNETT, GA
    LIGHTOWLER, S
    MURPHY, O
    DEBIASI, V
    STEVENS, N
    TULLOCH, LF
    BLACKBURN, TP
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 : U109 - U109
  • [33] Partial 5-HT1A receptor agonist activity by the 5-HT2C receptor antagonist SB 206,553 is revealed in rats spinalized as neonates
    Shumsky, JS
    Kao, T
    Amato, N
    Simansky, K
    Murray, M
    Moxon, KA
    EXPERIMENTAL NEUROLOGY, 2005, 191 (02) : 361 - 365
  • [34] Effects of 5-HT2C, 5-HT1A receptor challenges and modafinil on the initiation and persistence of gambling behaviours
    Humby, Trevor
    Smith, Georgia E.
    Small, Rebecca
    Davies, William
    Carter, Jenny
    Bentley, Chloe A.
    Winstanley, Catharine A.
    Rogers, Robert D.
    Wilkinson, Lawrence S.
    PSYCHOPHARMACOLOGY, 2020, 237 (06) : 1745 - 1756
  • [35] Effects of 5-HT2C, 5-HT1A receptor challenges and modafinil on the initiation and persistence of gambling behaviours
    Trevor Humby
    Georgia E. Smith
    Rebecca Small
    William Davies
    Jenny Carter
    Chloe A. Bentley
    Catharine A. Winstanley
    Robert D. Rogers
    Lawrence S. Wilkinson
    Psychopharmacology, 2020, 237 : 1745 - 1756
  • [36] SB 242084:: A selective 5-HT2C receptor antagonist
    Di Matteo, V
    Di Giovanni, G
    Esposito, E
    CNS DRUG REVIEWS, 2000, 6 (03): : 195 - 205
  • [37] Antagonist properties of atypical antipsychotics at the 5-HT2C receptor
    Wood, M
    Patel, N
    Heath, J
    FASEB JOURNAL, 2003, 17 (05): : A1022 - A1022
  • [38] Evidence for accelerated desensitisation of 5-HT2C receptors following combined treatment with fluoxetine and the 5-HT1A receptor antagonist, WAY 100,635, in the rat
    Bristow, LJ
    O'Connor, D
    Watts, R
    Duxon, MS
    Hutson, PH
    NEUROPHARMACOLOGY, 2000, 39 (07) : 1222 - 1236
  • [39] Investigation of the effect of WAY-100635 (5-HT1A receptor antagonist) on 5-HT-induced contraction in different regions of the suncus murinus intestine
    Javid, FA
    Naylor, RJ
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135
  • [40] Lower 5-HT1A receptor binding in patients with borderline personality disorder:: a PET study using [11C]WAY100635
    Jovanovic, H.
    Andersson, E. E.
    Karlsson, P.
    Halldin, C.
    Nordstroem, A. L.
    Asberg, M.
    Farde, L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S82 - S83
12345